期刊文献+

参芪强心胶囊治疗慢性心力衰竭患者临床疗效观察

Clinical Observation of Shen Qi Qiangxin Capsule on Chronic Heart Function
下载PDF
导出
摘要 目的观察参芪强心胶囊治疗慢性心力衰竭(CHF)患者的临床疗效.方法:把80 例心衰患者随机分成对照组、治疗组.对照组常规抗心力衰竭治疗,治疗组加服参芪强心胶囊,两组疗程均为4 周.结果:治疗组加用参芪强心胶囊后临床疗效、左室舒张末期内径、左室射血分数、6 分钟步行距离,血浆NT-proBNP 比治疗前明显改善,且明显优于对照组,并有显著性差异(P〈0.05).对照组治疗后左室舒张末期内径(LVEDD)、左室射血分数(LVEF)、6 分钟步行距离,血浆N 端前脑钠肽也有明显改善(P〈0.05).结论:参芪强心胶囊治疗心衰能改善心衰患者临床疗效,改善左室功能,而且安全性好. Objective:To investigate the effect of Shenqiqiangxin Capsule on Heart Function.Methods:80 patients were divided into randomly the treatment group and the control group. Both groups were treated with regular treatment for 4 weeks. Simultaneously the Shenqiqiangxin Capsule was added into the treatment group. Results: Clinical Efficacy、LVEDD、LVEF 、6MWD and NT-proBNP were promoted after therapy in the two groups,the deference of reatment group was obvious than control group.Conciusion: Shenqiqiangxin Capsule can improve the levels of LVEDD and NT-pro BNP in Patients with Chronic Heart Failuye and improve Clinical Efficacy,increased LVEF and 6MWD,improvement of left ventricular function and safety.
出处 《世界中医药》 CAS 2015年第A01期79-79,共1页 World Chinese Medicine
基金 安徽省卫计委中医药科研课题(编号2014zy70)
关键词 参芪强心胶囊 心力衰竭 N端前脑钠肽 临床观察 Shenqiqiangxin Capsule Chronic Heart Failuye NT-pro BNP Clinical Observation
  • 相关文献

参考文献2

二级参考文献31

  • 1裘宇芳,袁敏.心力衰竭患者血脑钠肽水平与心功能及预后的关系[J].心脑血管病防治,2005,5(1):53-54. 被引量:12
  • 2张春玲,康金锁,陈曦,张丽,张健,杨跃进,丛祥凤.心血管病患者血浆N端B型脑钠肽水平变化及其临床意义[J].中华检验医学杂志,2006,29(1):31-34. 被引量:38
  • 3王海玲,张灵,王乐,贾宁,王进,胡雪红,静国丽,张志莲.B型利钠肽与左室射血分数、NYHA心功能分级、P波终末电势及6分钟步行试验的相关性研究[J].中国心血管病研究,2007,5(7):502-504. 被引量:23
  • 4叶任高.内科学[M] 5版[M].北京:人民卫生出版社,2001.22-31.
  • 5张泽灵.心脏内科1000问[M].北京:军事医学科学出版社,2006:682.
  • 6Peter MK,Seigo I. Apoptosis and heart failure:a critical re- view of the literature [ J ]. Circ Res, 2000,86 : 1107-1113.
  • 7Yamamura T, Nakamura H, Yamamato T, et al. Fas expression and apoptosis correlated with cardiac dysfunction in patients with dilated cardiomvooathv[J]. Jon Circ J, 1999, 63:149-154.
  • 8Ishiyama S ,Hiroe M,Nishikawa T,et al. The Fas/Fas ligand system is involved in the pathogenesis of autoimmune my- ocarditis in rats[J]. J Immunol, 1998,161 : 4695-4701.
  • 9Laterence P, Cahalin MA, Michael A, et al. The six-minute walk test predicts peak oxygen uptake and survival in patients with ad- vanced heart failure. Chest, 1996, 110(3) :325-332.
  • 10Gualeni A, Dc Aloia A, Gentilini A, et al. Effects of maximally tolerated oral therapy on the six-minute walking test in patients with chronic congestive heart failure secondary to either ischemic or idio- pathic dilated cardiomyopathy. Am J Cardiol, 1998, 81(11) : 1370-1372.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部